
Please try another search
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company’s lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
David V. Goeddel | 72 | 2016 | Independent Chairman of the Board |
Jeffrey T. Walsh | 58 | 2020 | Independent Director |
Timothy Hoey | 65 | 2017 | Member of Scientific Advisory Board |
Eric N. Olson | - | - | Scientific Founder & Member of Scientific Advisory Board |
Faraz Ali | 51 | 2018 | CEO, Interim Principal Financial Officer & Director |
Deepak Srivastava | 58 | 2016 | Scientific Founder, Chairman of Scientific Advisory Board & Director |
June H. Lee | 59 | 2021 | Independent Director |
Jonathan S. Weissman | - | - | Member of Scientific Advisory Board |
Catherine Stehman-Breen | 62 | 2020 | Independent Director |
R. Sanders Williams | 76 | 2016 | Independent Director |
Mark A. Kay | 67 | - | Member of Scientific Advisory Board |
Douglas L. Mann | - | - | Member of Scientific Advisory Board |
Amy L. Burroughs | 55 | 2022 | Independent Director |
Karah Herdman Parschauer | 47 | 2021 | Independent Director |
Christine Edry Seidman | - | 2023 | Member of Scientific Advisory Board |
Alexander Marson | - | 2023 | Member of Scientific Advisory Board |
Barry J. Byrne | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review